Delivery Order SPE2DR25D9238-SPE2DR26FRRN7
Award Date 1/27/26
Potential Completion Date 2/18/26
Potential Value $1.2K
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order valued at $7,174.74 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of OMIDRIA 1-0.3% vials (4mL). The award, issued on October 31, 2025, with an ultimate completion date of November 24, 2025, utilizes a firm fixed-price delivery order structure with no set-aside designation, indicating the contractor competed in an unrestricted procurement. This delivery...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $4,881.56 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, for the supply of OMIDRIA 1-0.3% Vial 4ML. This firm fixed-price delivery order, issued on November 28, 2025, with an ultimate completion date of December 19, 2025, carries no set-aside designation, demonstrating the contractor's competitive capability in unrestricted federal procurement....
- The Defense Logistics Agency awarded a delivery order valued at $2,444.54 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for OMIDRIA 1-0.3% vials in 4 mL quantities. This delivery order, issued on January 13, 2026, with an ultimate completion date of February 4, 2026, represents a firm fixed-price purchase with no set-aside designation, demonstrating DMS Pharmaceutical Group's competitive capability in unrestricted...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a $7,174.74 firm fixed-price delivery order by the Defense Logistics Agency's Medical Supply Chain on September 22, 2025, for the supply of Omidria 1-0.3% vials (4ML). This delivery order is issued under the company's larger single-award Indefinite Delivery Contract (IDC) with the Defense Logistics Agency valued at $499,999,999 and valid through November 2026, which...
- The Defense Logistics Agency's Medical Supply Chain issued a delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of OMIDRIA 1-0.3% vials (4 mL) with a contract value of $2,391.60. This firm fixed-price delivery order was awarded on September 5, 2025, with an ultimate completion date of September 26, 2025. The award carries no set-aside designation, allowing DMS Pharmaceutical Group to compete...
- This contract award, valued at $4,983.96, was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is a firm fixed-price delivery order for the pharmaceutical product OMIDRIA 1-0.3% VIAL 4ML, with an ultimate completion date of July 22, 2024. DMS Pharmaceutical Group Inc. holds a significant indefinite delivery contract (IDC) with the DLA, valued at up to $499,999,999,...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $3,737.97, is for the delivery of OMIDRIA 1-0.3% vial, 4 mL, a pharmaceutical product. The contract has a firm fixed price and no set-aside designation. DMS Pharmaceutical Group Inc. holds a larger indefinite delivery contract (IDC) with the DLA, valued at up to $499,999,999,...
- DMS Pharmaceutical Group Inc. has been awarded a firm fixed price delivery order against its indefinite delivery contract with the Defense Logistics Agency to provide Omidria 1-0.3% Vial 4ML. The delivery order has a potential value of $5,753.55 and a completion date of December 11, 2023. DMS Pharmaceutical Group will supply the pharmaceutical item to DLA Troop Support Medical facilities from its place of performance in Park Ridge, Illinois. As a woman-owned small business and pharmaceutical...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $5,178.57 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. This firm fixed-price delivery order, issued on January 23, 2026, with an ultimate completion date of January 26, 2026, was made without a set-aside designation, demonstrating the contractor's competitive capability in unrestricted federal procurement. The delivery order falls under DMS...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,770.20 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois. This delivery order, issued on October 21, 2025, is issued under DMS Pharmaceutical Group's single-award Indefinite Delivery Contract (IDC) within the DLA's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative. The delivery order represents a firm fixed-price...